Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Immunogenetics. 2014 Aug 22;66(11):651–661. doi: 10.1007/s00251-014-0798-x

Table 4.

Residues at positions homologous to active site residues of human serotransferrin.

Site1 Clade2

Iron-binding S L ICA O M M-like

N-lobe 63 D D,G D,G D,G D,F,N,S D
95 Y Y Y,H Y Y I,T,V
188 Y Y Y,S Y Y,G N,S
249 H H,N H H H,R G,K,R
C-lobe 392 D D,G D D D,G,K,R,S D
426 Y Y Y,H Y Y,H A,L,V
517 Y Y F,P,S Y Y,D N
585 H H H,R H H,Q,R N,S
Carbonate-binding
N-lobe 124 R R,W R,C,W R,K R,Q W3
C-lobe 456 R R T3 R R,M,S S3
Mean amino acid diversity (%)4,5 0.0% 5.0% * 29.3% ** 2.4% 30.1% ** 28.4% *
No. conserved residues shared with S 10 6 2 8 1 2
1

Sites numbered as in human serotransferrin (NP_001054).

2

As in Figure 2.

3

Clade-specific conserved residue.

4

Amino acid diversity at the 10 active site residues.

5

Paired t-tests of the hypothesis that mean amino acid diversity equals that for S:

*

P < 0.05;

**

P < 0.01.